strawfield2
About
Immunohistochemistry-Based Consensus Molecular Subtypes being a Prognostic as well as Predictive Biomarker with regard to Adjuvant Chemotherapy inside Patients with Period 2 Intestinal tract Cancers.
Immunohistochemistry-Based Consensus Molecular Subtypes being a Prognostic as well as Predictive Biomarker with regard to Adjuvant Chemotherapy inside Patients with Period 2 Intestinal tract Cancers.